Response to ‘Comment on “Cost-Effectiveness of Niraparib...

  • Main
  • 2019 / 5
  • Response to ‘Comment on “Cost-Effectiveness of Niraparib...

Response to ‘Comment on “Cost-Effectiveness of Niraparib Versus Routine Surveillance, Olaparib and Rucaparib for the Maintenance Treatment of Patients with Ovarian Cancer in the United States”’

Guy, Holly, Walder, Lydia, Fisher, Mark
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
PharmacoEconomics
DOI:
10.1007/s40273-019-00803-7
Date:
May, 2019
File:
PDF, 494 KB
english, 2019
Conversion to is in progress
Conversion to is failed